Fresenius Kabi Deutschland GmbH

Friedberg, Germany

Fresenius Kabi Deutschland GmbH

Friedberg, Germany

Time filter

Source Type

Patent
Fresenius Kabi Deutschland GmbH | Date: 2017-03-22

Provided herein, generally, are pharmaceutical formulations, e.g., injectable pharmaceutical formulations with improved stability, comprising morphine sulfate or a hydrate thereof, and methods of producing and using the same. Also provided herein are kits comprising the formulations, e.g., injectable morphine formulations.


Patent
Fresenius Kabi Deutschland GmbH | Date: 2015-02-03

A gastrostomy tube (1) comprises a head (10) having a port (15) for feeding a fluid, a tube section (11) extending from the head (10) and having a duct (150) for transporting a fluid fed into the port (15), and a cap assembly (2) attachable to the head (10). Herein the cap assembly (2) comprises a cap (20) forming an inner chamber (205), wherein in an assembled state of the gastrostomy tube (1) the head (10) is inserted into the inner chamber (205) of the cap (20). In this way a gastrostomy tube is provided which allows for an aesthetically pleasing appearance of the head of the gastrostomy tube and represent an as small as possible obstacle for a patient in everyday life.


Patent
Fresenius Kabi Deutschland GmbH | Date: 2017-02-08

A gastrostomy tube (1) comprises a head (10) having a port (15) for feeding a fluid, a tube section (11) extending from the head (10) and having a duct (150) for transporting a fluid fed into the port (15), and a cap assembly (2) attachable to the head (10). Herein the cap assembly (2) comprises a cap (20) forming an inner chamber (205), wherein in an assembled state of the gastrostomy tube (1) the head (10) is inserted into the inner chamber (205) of the cap (20). In this way a gastrostomy tube is provided which allows for an aesthetically pleasing appearance of the head of the gastrostomy tube and represent an as small as possible obstacle for a patient in everyday life.


Patent
Fresenius Kabi Deutschland GmbH | Date: 2017-06-21

The present application is directed to an improved method for the detection of a starch in a sample comprising the steps of initially incubating the sample in the presence of an amylase and subsequently subjecting said sample to liquid chromatography mass spectrometry (LC-MS) to detect ions characteristic of the starch in the sample.


Patent
Fresenius Kabi Deutschland GmbH | Date: 2016-12-16

The present application is directed to methods for the detection of a starch in a sample. The methods comprise the steps of initially incubating the sample in the presence of an amylase and subsequently subjecting the sample to liquid chromatography mass spectrometry (LC-MS) to detect ions characteristic of the starch in the sample.


Patent
Fresenius Kabi Deutschland GmbH | Date: 2017-04-05

A drip chamber (1) for administering a medical fluid, comprises a chamber element (30) forming a chamber (300), an inlet (20) for letting a medical fluid into the chamber (300), and a connector (31) connected to the chamber element (30) at an outlet of the drip chamber (1). A tube (4) is connectable to the connector (31) for letting the medical fluid out of the chamber (300). Herein, the connector (31) is formed in one piece on the chamber element (30) by using injection molding, wherein the chamber element (30) is formed from a first material and the connector (31) is formed from a second material which is different from the first material. In this way a drip chamber is provided which allows for an easy, cost-efficient production and at the same time is easily squeezable and may provide a reliable, durable connection to a tube.


Patent
Fresenius Kabi Deutschland GmbH | Date: 2017-07-26

A blood processing apparatus (1) comprises a measurement device (8) having a first chamber element (80) for measuring a haematocrit value of a blood fluid, the first chamber element (80) comprising a first inlet port (800) connectable to a first reservoir container (2) for allowing a flow from the first reservoir container (2) into the first chamber element (80) and a first outlet port (801) for allowing a flow out of the first chamber element (80), and the second chamber element (81) comprising a second inlet port (810) for allowing a flow into the second chamber element (81) and a second outlet port (811) connectable to a second reservoir container (3) for allowing a flow out of the second chamber element (81) towards the second reservoir container (3). The blood processing apparatus furthermore comprises a first pump mechanism (600) for pumping a blood fluid in a flow direction (F1) from the first reservoir container (2) towards the blood processing apparatus (1), and a second pump mechanism (610) for pumping a blood fluid in a flow direction (F2) from the blood processing apparatus (1) towards the second reservoir container (2). Herein, the first pump mechanism (600) is located upstream of the first inlet port (800) of the first chamber element (80) and the second pump mechanism (610) is located upstream of the second inlet port (810) of the second chamber element (81). In this way a blood processing apparatus comprising a measurement device is provided which in an easy and reliable manner allows for a measurement of in particular a haematocrit value in the incoming blood flow as well as the outgoing blood flow.


Patent
Fresenius Kabi Deutschland GmbH | Date: 2017-07-26

A blood processing apparatus (1) comprises a measurement device (8) having at least one chamber element (80, 81) for receiving a blood fluid, wherein the at least one chamber element (80, 81) extends along a longitudinal axis (L) and comprises a circumferential wall (804, 814) extending about the longitudinal axis (L), a bottom wall (803, 813) and a top wall (805, 815) together defining a flow chamber (802, 812), the at last one chamber element (80, 81) further comprising an inlet port (800, 810) for allowing a flow of a blood fluid into the flow chamber (802, 812) and an outlet port (801, 811) for allowing a flow of a blood fluid out of the flow chamber (802, 812). The blood processing apparatus (1) further comprises a holder device (9) for holding the measurement device (8), the holder device (9) comprising a base (90) having a reception opening (900) for receiving the measurement device (8) and a closure element (91) movably arranged on the base (90) for locking the measurement device (8) in an inserted position in the reception opening (900). An ultrasonic sensor element (92, 93) of the holder device (9) is arranged on the base (90) and adapted to produce an ultrasonic sensor signal (P) for measuring a haematocrit value of a blood fluid in the flow chamber (802, 812). Herein, the ultrasonic sensor element (92, 93), in the inserted position of the measurement device (8), faces the bottom wall (803, 813) of the at least one chamber element (80, 81) for transmitting the ultrasonic signal (P) into the flow chamber (802, 812) through the bottom wall (803, 813). In this way a blood processing apparatus comprising a holder device for a measurement device is provided which allows to easily insert the measurement device into the holder device and allows for a reliable measurement of, in particular, a haematocrit value of a blood flow through the measurement device.


Patent
Fresenius Kabi Deutschland GmbH | Date: 2017-08-09

The present invention relates to a polysaccharide comprising, optionally substituted, monosaccharide units linked via alpha-glycosidic bonds for use in preventing metastasis formation and/or relapse by administration to a body cavity of a subject afflicted with cancer. The present invention further relates to a method for preventing metastasis formation in a subject afflicted with cancer, comprising administering said composition to a body cavity of said subject, and thereby preventing metastasis formation in said subject. The present invention also relates to a composition and to a kit comprising a polysaccharide and a pharmaceutically acceptable means of solubilizing the same and to a device comprising a polysaccharide and means for administering the same.


Patent
Fresenius Kabi Deutschland GmbH | Date: 2017-07-26

A tubing set for use in a blood processing apparatus comprises a measurement device (8) having at least one chamber element (80, 81) for measuring a haematocrit value of a blood fluid, wherein the at least one chamber element (80, 81) extends along a longitudinal axis (L) and comprises a circumferential wall (804, 814) extending about the longitudinal axis (L) and encompassing a flow chamber (802, 812), the at last one chamber element (80, 81) further comprising an inlet port (800, 810) for allowing a flow of a blood fluid into the flow chamber (802, 812) and an outlet port (801, 811) for allowing a flow of a blood fluid out of the flow chamber (802, 812). The tubing set furthermore comprises an inlet-side tube section (21, 31) connected to the inlet port (800, 810) and an outlet-side tube section (22, 30) connected to the outlet port (801, 811). Herein, the inlet port (800, 810) and the outlet port (801, 811) are arranged on the circumferential wall (804, 814) and are displaced with respect to each other along the longitudinal axis (L). In this way a tubing set comprising a measurement device is provided which in an easy and reliable manner allows for the measuring of a haematocrit value of a blood fluid.

Loading Fresenius Kabi Deutschland GmbH collaborators
Loading Fresenius Kabi Deutschland GmbH collaborators